IMPORTANT SAFETY INFORMATION:
Utira-C (Hyoscyamine Sulfate 0.12 mg, Methenamine 81.6 mg, Phenyl Salicylate 36.2 mg, Sodium Phosphate Monobasic 40.8 mg, Methylene Blue 10.8 mg)Tablets is indicated for the treatment of symptoms of irritative voiding, the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections, and for the relief of urinary tract symptoms caused by diagnostic procedures. Adverse reactions to Utira-C can include rapid pulse, flushing, blurred vision, dizziness, trouble breathing, dry mouth, nausea or vomiting, difficulty mictruition, and acute urinary retention. For full prescribing information, please click here.

If you do not have Adobe® Acrobat® Reader for viewing the pdfs shown above, you may download it free of charge by clicking here.